1. Home
  2. CLRB vs ASTC Comparison

CLRB vs ASTC Comparison

Compare CLRB & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • ASTC
  • Stock Information
  • Founded
  • CLRB 2002
  • ASTC 1984
  • Country
  • CLRB United States
  • ASTC United States
  • Employees
  • CLRB N/A
  • ASTC N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • ASTC Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CLRB Health Care
  • ASTC Industrials
  • Exchange
  • CLRB Nasdaq
  • ASTC Nasdaq
  • Market Cap
  • CLRB 10.7M
  • ASTC 11.9M
  • IPO Year
  • CLRB N/A
  • ASTC 1995
  • Fundamental
  • Price
  • CLRB $0.25
  • ASTC $7.65
  • Analyst Decision
  • CLRB Buy
  • ASTC
  • Analyst Count
  • CLRB 2
  • ASTC 0
  • Target Price
  • CLRB $28.00
  • ASTC N/A
  • AVG Volume (30 Days)
  • CLRB 3.8M
  • ASTC 39.7K
  • Earning Date
  • CLRB 11-18-2024
  • ASTC 02-10-2025
  • Dividend Yield
  • CLRB N/A
  • ASTC N/A
  • EPS Growth
  • CLRB N/A
  • ASTC N/A
  • EPS
  • CLRB N/A
  • ASTC N/A
  • Revenue
  • CLRB N/A
  • ASTC $1,273,000.00
  • Revenue This Year
  • CLRB N/A
  • ASTC N/A
  • Revenue Next Year
  • CLRB N/A
  • ASTC N/A
  • P/E Ratio
  • CLRB N/A
  • ASTC N/A
  • Revenue Growth
  • CLRB N/A
  • ASTC 11.96
  • 52 Week Low
  • CLRB $0.23
  • ASTC $6.56
  • 52 Week High
  • CLRB $4.45
  • ASTC $12.29
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 6.45
  • ASTC 65.10
  • Support Level
  • CLRB $0.23
  • ASTC $6.67
  • Resistance Level
  • CLRB $0.28
  • ASTC $8.15
  • Average True Range (ATR)
  • CLRB 0.07
  • ASTC 0.47
  • MACD
  • CLRB -0.10
  • ASTC 0.10
  • Stochastic Oscillator
  • CLRB 2.70
  • ASTC 90.32

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

Share on Social Networks: